Skip to main content
. 2020 Jun 2;9(1):1770565. doi: 10.1080/2162402X.2020.1770565

Figure 4.

Figure 4.

Anti-CD20 + no-alpha mutein combination therapy activates CD8+ T cell subset. Percentage of CD8+ T cells expressing IFNγ+ (a), perforin+ (b), and granzyme B+ (c) of spleens from C57Bl/6 mice analyzed by flow cytometry 14 days after challenge with 2 × 105 EL-4-huCD20 cells and treated with the described different treatments. Dotted lines represent the mean values obtained with isotype control-treated C57Bl/6 mice for the indicated population. Data correspond to two independent experiments (n = 4–7 per group). Horizontal bars represent the mean ± SD (Kruskal-Wallis, Dunn’s post hoc test, *, P < .05; **, P < .01; ***, P < .001; ns, not significant).